Retraction: PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease.
出版信息
PLoS One. 2024 Dec 19;19(12):e0316408. doi: 10.1371/journal.pone.0316408. eCollection 2024.
Abstract
摘要
相似文献
1
Retraction: PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease.撤回声明：PrPST，一种可溶、抗蛋白酶且截短的朊蛋白形式，在一种遗传性朊病毒病的发病机制中具有特征性表现。
PLoS One. 2024 Dec 19;19(12):e0316408. doi: 10.1371/journal.pone.0316408. eCollection 2024.
2
Correction: PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease.更正：PrPST，一种可溶性、抗蛋白酶且截短的PrP形式，是一种遗传性朊病毒病发病机制的特征。
PLoS One. 2015 Jul 20;10(7):e0133911. doi: 10.1371/journal.pone.0133911. eCollection 2015.
3
PrP(ST), a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease.朊病毒蛋白（PrP(ST)）是一种可溶性、抗蛋白酶和截断的朊病毒蛋白形式，其特征在于一种遗传性朊病毒病的发病机制中。
PLoS One. 2013 Jul 26;8(7):e69583. doi: 10.1371/journal.pone.0069583. Print 2013.
4
Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease.朊病毒感染的生化特征：异常全长和N端截短的PrP蛋白积累是小鼠朊病毒病的常见特征。
J Virol. 2005 Jan;79(2):934-43. doi: 10.1128/JVI.79.2.934-943.2005.
5
Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.朊病毒蛋白疏水结构域内的致病性突变会导致形成具有更高致死率的蛋白酶敏感型朊病毒。
J Virol. 2014 Mar;88(5):2690-703. doi: 10.1128/JVI.02720-13. Epub 2013 Dec 18.
6
A novel human disease with abnormal prion protein sensitive to protease.一种新型人类疾病，其朊病毒蛋白异常且对蛋白酶敏感。
Ann Neurol. 2008 Jun;63(6):697-708. doi: 10.1002/ana.21420.
7
Allelic origin of protease-sensitive and protease-resistant prion protein isoforms in Gerstmann-Sträussler-Scheinker disease with the P102L mutation.伴有 P102L 突变的格斯特曼-施特劳斯勒-谢因克病中蛋白酶敏感型和蛋白酶抗性朊病毒蛋白异构体的等位基因来源。
PLoS One. 2012;7(2):e32382. doi: 10.1371/journal.pone.0032382. Epub 2012 Feb 23.
8
Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.C1截短型朊病毒蛋白比例增加可抵御细胞的M1000朊病毒感染。
J Neuropathol Exp Neurol. 2009 Oct;68(10):1125-35. doi: 10.1097/NEN.0b013e3181b96981.
9
Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.人星形胶质细胞对异常人类朊病毒蛋白聚集体的蛋白酶敏感型和抗性型的摄取与降解
Am J Pathol. 2014 Dec;184(12):3299-307. doi: 10.1016/j.ajpath.2014.08.005. Epub 2014 Sep 30.
10
Attempts to convert the cellular prion protein into the scrapie isoform in cell-free systems.在无细胞系统中尝试将细胞朊蛋白转化为瘙痒病异构体。
J Virol. 1992 Oct;66(10):6155-63. doi: 10.1128/JVI.66.10.6155-6163.1992.
本文引用的文献
1
Correction: PrPST, a Soluble, Protease Resistant and Truncated PrP Form Features in the Pathogenesis of a Genetic Prion Disease.更正：PrPST，一种可溶性、抗蛋白酶且截短的PrP形式，是一种遗传性朊病毒病发病机制的特征。
PLoS One. 2015 Jul 20;10(7):e0133911. doi: 10.1371/journal.pone.0133911. eCollection 2015.
2
PrP(ST), a soluble, protease resistant and truncated PrP form features in the pathogenesis of a genetic prion disease.朊病毒蛋白（PrP(ST)）是一种可溶性、抗蛋白酶和截断的朊病毒蛋白形式，其特征在于一种遗传性朊病毒病的发病机制中。
PLoS One. 2013 Jul 26;8(7):e69583. doi: 10.1371/journal.pone.0069583. Print 2013.
Zotero 插件